Screener
MapLight Therapeutics, Inc. MPLT Q2 2026 earnings
Reported September 18, 2026
EPS-$1.32Beat by $0.03
EPS estimate-$1.35
Next report
Dec 3, 2026 (in 2 months)EPS estimate-$1.22
Versus estimates
Diluted EPS
Q2 2026-$1.32Beat by $0.03
Q1 2026-$1.32Beat by $0.03Q4 2025-$1.34Miss by $0.38Q3 2025-$37.18Miss by $35.46FAQ
- When did MapLight Therapeutics, Inc. report Q2 2026 earnings?
- MapLight Therapeutics, Inc. (MPLT) reported Q2 2026 earnings on September 18, 2026.
- What were MapLight Therapeutics, Inc.'s Q2 2026 revenue and EPS?
- MapLight Therapeutics, Inc. reported eps of $-1.32 for Q2 2026.
- Did MapLight Therapeutics, Inc. beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-1.35 by $0.03.
- Where can I find MapLight Therapeutics, Inc.'s Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001193125-26-349554) directly on SEC EDGAR. The filing index links above go to sec.gov.
